arbrnrngr

Author Archives

Recent Author Comments

On Microblog: What is Steve Sjuggerud ‘s next bull market?
Can't be anything but China if it's Steve. Full disclosure, I like his thought process, follow him pretty closely and I've made good money on his trends. Having been to China a number of times, I tend to come to the same conclusions he suggests. Of course[...]
On Biotech Discussion... continued
Cleveland, I did some search work for Tony (CEO at Closure), and thought there was an application for closing internal wounds, sub cutaneously. I could be wrong. Also, don't forget, Closure basically used SuperGlue. J&J's OTC product initially licensed fro[...]
On Dr. KSS Posts from Biotech Showcase 2018, San Francisco
$biotech ? Cleveland and Dr. KSS, my dilemma is sometimes I have rather intimate/inside info on some of the co's discussed on this site that I'd prefer to not make attributable to me yet that are clearly important to assess an investment (Doc, I reached o[...]
On Dr. KSS Posts from Biotech Showcase 2018, San Francisco
Personally, not sure I'd touch this team as an investment. I'm holding my tongue on a number of "covered" companies that, from a personnel perspective, rate very low in my opinion. Yes, I too spent 5 days in SFO for the 25th time in my career. My advic[...]
On Microblog: Marijuana Companies For Investing
Hey PJ, how did that $3k bitcoin investment end up?[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
$BioMarin Interesting UK study Hemophilia A success. Small study but quite the patient response.[...]
On "Notes from Torrey Hills Capital Emerging Growth Conference, 13-15 November 2017, San Diego, CA"
Matthew, try my email at kreltub@gmail.com. I have some thoughts and direct insights on this.[...]
On "Notes from Torrey Hills Capital Emerging Growth Conference, 13-15 November 2017, San Diego, CA"
$ZIOP - NEVER a position!! Cleveland, I did the early work here with Jon Lewis and actually shared some adjacent office space with him. This was/and-still-is a team I'd never touch with 10 foot pole.[...]
On Tear Sheet: CohBar Inc. ($CWBR)
$ONCYF (small position) just announced a major deal yesterday. I think they also trade on TSX under different ticker. Very interesting company from my due diligence. I also know the team well and feel they can get this over the goal line (assuming the tec[...]
On Microblog: Venture Technology
$VRAY (full position) I'm guessing Varian or ViewRay. More investigation will make this one obvious... I'm went ViewRay but admit my diligence was (somewhat) quick.[...]
On "Notes from Torrey Hills Capital Emerging Growth Conference, 13-15 November 2017, San Diego, CA"
bump[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Lingling88, I know Mayleben fairly well and did several searches for the original esperion of the early 2000's. Tim is a 2d or 3d tier player. I personally would never invest in him. That said, one needs to look at the underlying tech in $ESPR. Having sa[...]
On Tear Sheet: CohBar Inc. ($CWBR)
$PIRS NP. Know some of the folks here: Pieris just going through a reorg and letting some key people go in order to conserve cash. They got in (or soon will get as SoGiAm pointed out) several years of cash and will now focus on delivering in the clinic. [...]
On Tear Sheet: CohBar Inc. ($CWBR)
Macchiarini is dirty and coated in teflon. He's despised within BSTG to this day. Green (previous CEO) will admit he was hoodwinked by this slick talking, slime bucket who cut every corner possible. Having said that, he implanted around 10 of their org[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Looking at the $PTLA exec team there's no REGULATORY depth unless they're using virtual expertise (e.g. outside consultants). Seen this movie many times before - CEO is a commercial guy and fails to surround himself with the skills he/she lacks. In this ca[...]
On Aurinia R&D Day, New York City, October 20, 2017
I've had some previous-company interaction with some of the current team and board: those I know are mediocre (at best). Doc KSS, I trust your instincts here and bet you're right that they pursuing failure.[...]
On Tear Sheet: CohBar Inc. ($CWBR)
$PTCT Gotta agree, this is a management team of zero. Unless they "happen" to be VERY lucky, there is nothing here.[...]
On Tear Sheet: CohBar Inc. ($CWBR)
$ORPN UPDATE FOR Dr. KSS (et al) First/initial Ph 2 open label study had sites in Montreal and Jerusalem. That study's results were announced at least a year ago. Next up is another Ph 2, double blind placebo controlled. I think the timing was just [...]
On Tear Sheet: CohBar Inc. ($CWBR)
OK, i know this team and company very well and have some very early stock having worked with them. There are some leadership challenges (Fred's a great guy - it's not him) and the science is interesting however the initial trial work (e.g. protocols) were [...]
On Tear Sheet: CohBar Inc. ($CWBR)
So top line on $ESPR will either be a partnership or the readout of their LT Phase 3 safety study which was initiated in early 2016. On the latter, it will likely be late 1stQ or early 2ndQ 2018[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch